BriaCell Therapeutics Intends To Offer To Sell Common Shares And Warrants In Public Offering; No Terms Disclosed
BriaCell Therapeutics Intends To Offer To Sell Common Shares And Warrants In Public Offering; No Terms Disclosed
BriaCell Therapeutics打算公開發行普通股和Warrants; 沒有透露條款
All of the common shares and warrants are to be sold by the Company. The Company intends to use the net proceeds from the offering primarily for working capital requirements, general corporate purposes, and the advancement of business objectives.
所有板塊的普通股和Warrants將由公司出售。公司計劃主要將此次發行的淨收益用於滿足營運資金需求、一般公司事務以及推動業務目標。
譯文內容由第三人軟體翻譯。
以上內容僅用作資訊或教育之目的，不構成與富途相關的任何投資建議。富途竭力但無法保證上述全部內容的真實性、準確性和原創性。
資訊熱榜
更新時間